Biothera Pharmaceuticals biothera.com


Public list: Pharma Startups (4734) Cancer Therapeutics (1145)

Biothera Pharmaceuticals is advancing Imprime PGG, a unique cancer immunotherapy, through Phase 2 clinical trials in multiple cancer indications in combination with checkpoint inhibitor therapy. While cancers can actively avoid detection by the immune system, Imprime PGG works as an immunological "ignition switch" to trigger a cascade of responses throughout the innate immune system that culminate in T cell activation. Imprime PGG synergizes with immune checkpoint inhibitors that unleash tumor k...Show all

Biothera Pharmaceuticals is advancing Imprime PGG, a unique cancer immunotherapy, through Phase 2 clinical trials in multiple cancer indications in combination with checkpoint inhibitor therapy. While cancers can actively avoid detection by the immun...Show all

Company (Alive / Active)

Phone: 651-675-0300

Fax:

3388 Mike Collins Drive
Suite A
Saint Paul, 55121
Minnesota, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Biothera Pharmaceuticals $16.2M May 11, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Biothera Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Beta-glucan compounds, compositions, and methods May 09, 2012 Apr 17, 2018 Patent
�-glucan assay methods Dec 01, 2014 Feb 06, 2018 Patent
Compositions including β-glucans and methods of use Sep 07, 2012 Jul 04, 2017 Patent
Glucan preparations Jun 15, 2007 Apr 04, 2017 Patent
Use of beta-glucans against biological warfare weapons and pathogens including anthrax Aug 30, 2010 Oct 21, 2014 Patent
See all 18 patents